| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Nov 7, 2024 | Tango Therapeutics, Inc. | Other | Sell | 16.3 | -3,080,000 | -46.03% | ✗ | $9.7M |
| Oct 25, 2024 | Oct 28, 2024 | Tango Therapeutics, Inc. | Other | Sell | 17.5 | -633,000 | -4.39% | ✗ | $4.3M |
| Oct 21, 2024 | Oct 23, 2024 | Tango Therapeutics, Inc. | Other | Sell | 16.3 | -875,000 | -5.72% | ✗ | $6.1M |
| Jun 28, 2024 | Jul 2, 2024 | Tango Therapeutics, Inc. | Other | Sell | 17.5 | -234,731 | -68.33% | ✗ | $2.1M |
| Jun 6, 2024 | Jun 7, 2024 | Tango Therapeutics, Inc. | Other | Sell | 20.0 | -140,000 | -28.66% | ✗ | $985.9K |
| May 1, 2024 | May 3, 2024 | Tango Therapeutics, Inc. | Other | Sell | 17.5 | -210,000 | -30.28% | ✗ | $1.6M |
| Oct 13, 2023 | Oct 17, 2023 | Tango Therapeutics, Inc. | Other | Buy | 96.3 | +1,250,000 | 8.53% | ✗ | $8.7M |
| Oct 13, 2023 | Oct 17, 2023 | Tango Therapeutics, Inc. | Other | Buy | 96.3 | +1,250,000 | 8.53% | ✗ | $8.7M |
| Oct 9, 2023 | Oct 11, 2023 | Tango Therapeutics, Inc. | Other | Sell | 17.5 | -225,000 | -2.86% | ✗ | $2.2M |
| Aug 11, 2023 | Aug 15, 2023 | Tango Therapeutics, Inc. | Other | Buy | 95.0 | +475,000 | 6.43% | ✗ | $2.4M |
| Feb 9, 2023 | Feb 13, 2023 | Tyra Biosciences, Inc. | 10% Owner | Sell | 17.5 | -265,568 | -92.18% | ✗ | $3.5M |
| Oct 11, 2022 | Oct 13, 2022 | Tango Therapeutics, Inc. | Director | Buy | 92.5 | +237,000 | 3.21% | ✗ | $1M |
| Sep 17, 2021 | Sep 17, 2021 | Tyra Biosciences, Inc. | 10% Owner | Buy | 100.0 | +625,000 | 10.97% | ✗ | $10M |
| Sep 25, 2020 | Sep 29, 2020 | PMV Pharmaceuticals, Inc. | Other | Buy | 100.0 | +950,000 | 100.00% | ✗ | $17.1M |